STAT+: GLP-1 drug helped type 1 diabetes patients keep healthy glucose levels and lose weight
\n \t
\n
<\/BR>
\n
\n \t
\n
<\/BR><\/p>\n
Obesity drugs were first approved to treat type 2 diabetes, but there\u2019s a growing movement to test them in type 1 diabetes, too. Research presented Monday at a large diabetes meeting showed some promise for this approach.<\/p>\n
Patients who took a GLP-1 drug fared better than those in a control group at keeping their blood glucose levels in a healthy range while also losing more weight than those who weren\u2019t taking the drug.<\/p>\n
The double-blinded, randomized control trial enrolled 72 adults with a BMI of 30 or higher who use automated insulin delivery systems to manage their type 1 diabetes. Split into two groups, half received weekly 1-milligram injections of semaglutide \u2014 the preferred GLP-1 drug and dose when the study was designed five years ago \u2014 and half received a placebo.\u00a0<\/p>\n
Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n